Pura Vida Investments’s AngioDynamics ANGO Stock Holding History

Pura Vida Investments’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-100,000	Closed	-$1.23M	–	79
2016 Q1	$1.23M	Buy	+100,000	New	+$1.1M	0.56%	55

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Pura Vida Investments's ANGO Position: Q3 2018 in Review

Pura Vida Investments sold out of AngioDynamics (ANGO) in Q3 2018, closing a stake of 50,842 shares — an estimated $1.13M sold.

Pura Vida Investments first reported a position in ANGO in Q1 2015 and held it in 2 quarters. The position peaked at $2.22M in Q1 2015. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.

Pura Vida Investments reported no remaining AngioDynamics position as of Q3 2018 after selling out during the quarter.
Pura Vida Investments sold 50,842 AngioDynamics shares in Q3 2018, an estimated $1.13M.
Pura Vida Investments first reported a position in AngioDynamics in Q1 2015 and held it in 2 quarters.
Pura Vida Investments's AngioDynamics position peaked at $2.22M in Q1 2015.
177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.

Based on Pura Vida Investments's 13F filing for Q3 2018, filed 14 Nov 2018.